São Paulo, Brazil

Adriana Invitti


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Adriana Invitti: Innovator in Ischemic Tissue Cell Therapy

Introduction

Adriana Invitti is a prominent inventor based in São Paulo, Brazil. She has made significant contributions to the field of medical therapies, particularly in the treatment of ischemic diseases. Her innovative approach focuses on utilizing cell therapy to address critical health conditions.

Latest Patents

Adriana Invitti holds a patent for her invention titled "Ischemic Tissue Cell Therapy." This patent encompasses compositions and methods for treating ischemic diseases and conditions, specifically targeting myocardial, CNS/brain, and limb ischemia. The invention details methods of treating disorders by administering monocytes obtained from various sources, including umbilical cord blood, peripheral blood, or bone marrow. The therapeutic efficacy is achieved by administering these cells at a strategically determined time point. One notable application of her invention involves injecting the cells into ischemic myocardium to treat angina.

Career Highlights

Throughout her career, Adriana has worked with notable organizations, including Cryopraxis Criobiologia Ltda. and the Federal University of São Paulo (Universidade Federal De São Paulo—UNIFESP). Her work in these institutions has allowed her to advance her research and contribute to the medical field significantly.

Collaborations

Adriana has collaborated with esteemed colleagues such as Paul R. Sanberg and Nelson Americo Hossne, Jr. These partnerships have enriched her research and expanded the impact of her innovations in the medical community.

Conclusion

Adriana Invitti is a trailblazer in the field of ischemic tissue cell therapy, with her innovative patent paving the way for new treatment options for ischemic diseases. Her contributions to medical science highlight the importance of research and collaboration in advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…